5775-90-6 Usage
Description
Ethyl 4-bromo-1,5-dimethylpyrazole-3-carboxylate, also known as 4-Bromo-1,5-dimethyl-3-carboxyethylpyrazole, is a chemical compound that belongs to the class of pyrazole derivatives. It is commonly used in pharmaceutical research and organic synthesis, particularly in the development of potential drug candidates. Ethyl 4-bromo-1,5-dimethylpyrazole-3-carboxylate has shown potential as an antioxidant, anti-inflammatory, and antimicrobial agent, and has been studied for its potential use in the treatment of various diseases and conditions. It is important to handle this compound with caution and follow proper safety protocols, as it can be hazardous if not used properly.
Uses
Used in Pharmaceutical Research:
Ethyl 4-bromo-1,5-dimethylpyrazole-3-carboxylate is used as a research compound for the development of potential drug candidates due to its diverse pharmacological properties.
Used in Organic Synthesis:
Ethyl 4-bromo-1,5-dimethylpyrazole-3-carboxylate is used as a synthetic intermediate in the preparation of various organic compounds.
Used in Antioxidant Applications:
Ethyl 4-bromo-1,5-dimethylpyrazole-3-carboxylate is used as an antioxidant agent, which can help protect cells from oxidative damage and may have potential applications in the prevention and treatment of various diseases.
Used in Anti-inflammatory Applications:
Ethyl 4-bromo-1,5-dimethylpyrazole-3-carboxylate is used as an anti-inflammatory agent, which can help reduce inflammation and may have potential applications in the treatment of inflammatory conditions.
Used in Antimicrobial Applications:
Ethyl 4-bromo-1,5-dimethylpyrazole-3-carboxylate is used as an antimicrobial agent, which can help inhibit the growth of microorganisms and may have potential applications in the treatment of infections.
Used in Disease Treatment:
Ethyl 4-bromo-1,5-dimethylpyrazole-3-carboxylate has been studied for its potential use in the treatment of various diseases and conditions, including its antioxidant, anti-inflammatory, and antimicrobial properties.
Check Digit Verification of cas no
The CAS Registry Mumber 5775-90-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,7 and 5 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5775-90:
(6*5)+(5*7)+(4*7)+(3*5)+(2*9)+(1*0)=126
126 % 10 = 6
So 5775-90-6 is a valid CAS Registry Number.
5775-90-6Relevant articles and documents
2-AZABICYCLO[3.1.1] DERIVATIVES AS ANTAGONISTS OF THE OREXIN-1 AND OREXIN-2 RECEPTORS
-
, (2019/05/15)
There is provided a compound of formula I, wherein L1, R1, R2, R5, X, A and B have meanings given in the description, and pharmaceutically acceptable salts, solvates and prodrugs thereof, which compounds are useful as antagonists of the orexin-1 and orexin-2 receptors or as selective antagonists of the orexin-1 receptor, and thus, in particular, in the treatment or prevention of inter alia substance dependence, addiction, anxiety disorders, panic disorders, binge eating, compulsive disorders, impulse control disorders, cognitive impairment and Alzheimer's disease.
MACROCYCLIC INDOLE DERIVATIVES
-
Page/Page column 197, (2019/06/09)
The present invention relates to macrocyclic indole derivatives of general formula (I), in which R1, R2, R3, R4, R5, R6, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
MACROCYCLIC CHLORINE SUBSTITUTED INDOLE DERIVATIVES
-
Page/Page column 191, (2019/06/09)
The present invention relates to macrocyclic indole derivatives of general formula (I) : in which R1, R2, R3, R4, R5, R6, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
